SCHEMBL23488252

SCHEMBL23488252

COC(=O)[C@H](CCCCNC(=O)CCCC(=O)NCc1cccc(COc2c(Cl)cc(C(=O)N[C@H]3[C@@H](OC)O[C@H](CO)[C@@H](O)[C@@H]3O)c(C)c2Cl)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 5/20 0.40
KLK5 Q9Y337 4/20 0.40
MAPT P10636 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
CTSK P43235 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
LGALS1 P09382 1/20 0.31
LGALS3 P17931 1/20 0.31
LGALS7; LGALS7B P47929 1/20 0.31
SIRT5 Q9NXA8 1/20 0.31
CYP3A4 P08684 1/20 0.31
ITGB3 P05106 1/20 0.31
ITGA2B P08514 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488627 0.98 KLK7 (0.39) KLK7KLK5MAPTNPSR1MEN1
SCHEMBL23488793 0.98 KLK7 (0.39) KLK7KLK5MAPTNPSR1MEN1
SCHEMBL23488782 0.98 KLK7 (0.40) KLK7KLK5MAPTNPSR1MEN1
SCHEMBL23488626 0.94 KLK7 (0.37) KLK7KLK5MAPTNPSR1MEN1
SCHEMBL23488751 0.94 KLK7 (0.39) KLK7KLK5MAPTNPSR1KMT2A
SCHEMBL23488339 0.92 KLK7 (0.38) KLK7KLK5MAPTNPSR1BCHE
SCHEMBL23486306 0.92 KLK7 (0.38) KLK7KLK5MAPTNPSR1BCHE
SCHEMBL23488795 0.90 KLK7 (0.37) KLK7KLK5MAPTNPSR1MEN1
SCHEMBL23488608 0.88 KLK7 (0.37) KLK7KLK5MAPTNPSR1MEN1
SCHEMBL23488774 0.88 KLK7 (0.38) KLK7KLK5MAPTNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 KLK7 2859/4885KLK5 3345/4885MAPT 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.